Therapeutic effect of gedatolisib, a pan-PI3K/mTOR inhibitor, on[...]
University of Massachusetts Amherst
Risk Anticipation Isn’t Covered in Drivers’ Ed – UMass Amherst[...]
A Phase 3 study of gedatolisib plus fulvestrant with and without[...]
07/22/2024 | Press release | Distributed by Public on 07/22/2024 07:21
Please select the service you want to use:
Smartlinks | Warner Music Group Corporation | News | Local News | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Arts and Culture | Entertainment | Music | Securities Issuers | Music Production and Distribution Companies | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Hannover Stock Exchange | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact